Samstag, 6. April | 08:30 - 10:00 Uhr | Saal 6
Sitzungen
Innovation in Cardiovascular Prevention
Vorsitz/Chair: Nicolle Kränkel (Berlin), Harm Wienbergen (Lübeck)
Agenda
08:30
(V1819)
Introduction
N. Kränkel (Berlin)
08:35
(V1821)
Lessons learned from the global consortium And the winner is: Arterial hypertension!
C. Magnussen (Hamburg)
08:46
Discussion
08:51
(V1822)
LDL cholesterol – Reduction of CVD – But what about overall mortality? PURE, Global Cardiovascular Risk Consortium and Europe
M. Kavousi (Rotterdam)
09:02
Discussion
09:07
(V1823)
GLP1-RA from of a weight-loss substance to a strategy to reduce cardiovascular events The metamorphosis
M. Kelm (Düsseldorf)
09:18
Discussion
09:23
(V1824)
Reduction of CVD burden in GermanyThe strategic perspective of the National Heart Alliance
T. Voigtländer (Frankfurt am Main)
09:34
Discussion
09:39
(V1820)
Secondary Prevention after ACSThe European Perspective
T. F. Lüscher (Zürich)
09:50
Discussion
09:55
(V1825)
Conclusion
H. Wienbergen (Lübeck)
10:00 - 11:30